Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Treatment Intensification (Combination Therapy)

Plan

Treatment Intensification (Combination Therapy)

Actual

Describe Intervention

(Select ONE; useBPAA Project Roadmap for ideas on evidence-based strategies)

Chosen intervention: Adopt and activate a hypertension management algorithm based on participation in SMBP

Plan for intervention:

-Review algorithm examples

-Present algorithm to providers

-Revise algorithm as needed

-Activate algorithm

Chosen Intervention:

Date when implemented:

Updates: 12/19 in the last month have just received Azara data nd in the process of validation -making sure SMBP data is flowing into Azara properly, other BP data is already validated. Dr Joy will review algorithms in the next month

Reach (#/% patients – or providers, for provider-facing interventions – who participated in intervention)

Reach of implementers/providers?

Planned:

20% of providers

Reach of implementers/providers?

Actual:

Reach of patients (# of patients receiving treatment intensification)?

Planned:

  • # AA pts. w/uncontrolled HTN on no therapy: 30%

  • # AA pts. w/uncontrolled HTN on monotherapy: 30%

Reach of patients (# of patients receiving treatment intensification)?

Actual:

Efficacy (Impact of intervention on important outcomes)

How will you measure that your intervention is working?

will start with a list of patients in i2i using patient search feature and also look at pts w/ uncontrolled htn on 1 medication

  • List of patients meeting the criteria will be distributed

  • Patients submitting BP for SMBP

  • Whether RN has had an encounter with patients enrolled in SMBP

  • Treatment intensification has been communicated to provider

  • Treatment intensification has been activated.

Were you able to accurately measure how your intervention was working?

What outcomes do you expect?

  • Need to reactivate SMBP patient participation

  • 5-10% of patients will be unreachable

  • Some providers will not buy in

What outcomes have you seen?

How will you ensure your intervention will be effective for your target population?

  • Consistent participation with HFP to brainstorm

  • Consistent education and communication with providers and patients

  • Ongoing review of the algorithm

  • Data to demonstrate progress at the provider level

  • Review progress with Medical director and other center leadership

Did your intervention reach the target population?

What unintended consequences or outcomes might there be?

  • Staffing challenges

  • Pharmacy benefit challenges

What unintended outcomes did you experience?

Adoption (#/% and representativeness of staff and sites who implemented the intervention)

How did clinicians respond to interventions to intensify medication more rapidly/address therapeutic inertia?

Who will deliver the intervention (actually do the work)? Include staff and sites, if applicable.

Dr. Joy, Diane, Rafaela

Who delivered the intervention? Did they have the skills and time needed to complete the intervention?

How will you know if clinicians/care teams/sites used the intervention?

  • Increased # of referrals for SMBP

  • Who is referring patients to smbp

  • Review of medications and # of intensifications

What proportion of the planned staff/sites implemented the intervention?

Were there any differences between care teams/sites who adopted the intervention best vs. others who did not (e.g., differences in staff types, capacity, etc.)?

Implementation Fidelity (How closely the staff/sites followed the intervention design, delivered it as intended – also called fidelity to the intervention)

How will you know what adaptations or modifications were made during the intervention?

How did you track modifications during the intervention?

What might be some of the possible obstacles to consistent implementation?

What were the barriers to consistent intervention implementation?

What costs and resources (including time and burden, not just money) need to be considered?

What costs and resources (including time and burden, not just money) need to be considered?

How closely did the staff/sites follow the intervention design and deliver as intended?

Check all that apply:

  •  Followed as designed
  •  Followed with minor modifications
  •  Followed somewhat as designed
  •  Not followed as design
  •  Delivered consistently/as intended
  •  Delivered somewhat consistently/somewhat as intended
  •  Delivered inconsistently/not as intended

Modifications made and other notes:

Maintenance (Extent to which intervention is part of routine practices and protocols)

What reinforcements will you put in place to sustain the intervention, if effective?

  •  Protocols
  •  Clinical decision support (alerts, order sets, templates, registries)
  •  Policies
  •  Regular training
  •  Regular reports
  •  Incentives
  •  Other:

Explain:

What reinforcements did you put into place to sustain the intervention?

  •  Protocols
  •  Clinical decision support (alerts, order sets, templates, registries)
  •  Policies
  •  Regular training
  •  Regular reports
  •  Incentives
  •  Other:

Explain:

How will you spread your intervention and lessons learned?

How will you spread your intervention and lessons learned?

What are likely modifications or adaptations that will need to be made to sustain the intervention over time (e.g., lower cost, different staff, reduced intensity, different settings)?

Intervention #2

Plan

Intervention #2

Actual

Describe Intervention

(Select ONE; useBPAA Project Roadmap for ideas on evidence-based strategies)

Chosen intervention: already are working on registries due to Azara implementation - may be looking at this down the road after Azara implementation (note about large number of patients (no n yet) who have been graduated by Diane from SMBP

Plan for intervention:

Chosen Intervention:

Date when implemented:

Updates:

Reach (#/% patients – or providers, for provider-facing interventions – who participated in intervention)

Reach of implementers/providers?

Planned:

Reach of implementers/providers?

Actual:

Reach of patients (# of patients receiving treatment intensification)?

Planned:

  • # AA pts. w/uncontrolled HTN on no therapy (as of 6/30/2023):

  • # AA pts. w/uncontrolled HTN on monotherapy (as of 6/30/2023):

Reach of patients (# of patients receiving treatment intensification)?

Actual:

Efficacy (Impact of intervention on important outcomes)

How will you measure that your intervention is working?

Were you able to accurately measure how your intervention was working?

What outcomes do you expect?

What outcomes have you seen?

How will you ensure your intervention will be effective for your target population?

Did your intervention reach the target population?

What unintended consequences or outcomes might there be?

What unintended outcomes did you experience?

Adoption (#/% and representativeness of staff and sites who implemented the intervention)

How did clinicians respond to interventions to intensify medication more rapidly/address therapeutic inertia?

Who will deliver the intervention (actually do the work)? Include staff and sites, if applicable.

Who delivered the intervention? Did they have the skills and time needed to complete the intervention?

How will you know if clinicians/care teams/sites used the intervention?

What proportion of the planned staff/sites implemented the intervention?

Were there any differences between care teams/sites who adopted the intervention best vs. others who did not (e.g., differences in staff types, capacity, etc.)?

Implementation Fidelity (How closely the staff/sites followed the intervention design, delivered it as intended – also called fidelity to the intervention)

How will you know what adaptations or modifications were made during the intervention?

How did you track modifications during the intervention?

What might be some of the possible obstacles to consistent implementation?

What were the barriers to consistent intervention implementation?

What costs and resources (including time and burden, not just money) need to be considered?

What costs and resources (including time and burden, not just money) need to be considered?

How closely did the staff/sites follow the intervention design and deliver as intended?

Check all that apply:

  •  Followed as designed
  •  Followed with minor modifications
  •  Followed somewhat as designed
  •  Not followed as design
  •  Delivered consistently/as intended
  •  Delivered somewhat consistently/somewhat as intended
  •  Delivered inconsistently/not as intended

Modifications made and other notes:

Maintenance (Extent to which intervention is part of routine practices and protocols)

What reinforcements will you put in place to sustain the intervention, if effective?

  •  Protocols
  •  Clinical decision support (alerts, order sets, templates, registries)
  •  Policies
  •  Regular training
  •  Regular reports
  •  Incentives
  •  Other:

Explain:

What reinforcements did you put into place to sustain the intervention?

  •  Protocols
  •  Clinical decision support (alerts, order sets, templates, registries)
  •  Policies
  •  Regular training
  •  Regular reports
  •  Incentives
  •  Other:

Explain:

How will you spread your intervention and lessons learned?

How will you spread your intervention and lessons learned?

What are likely modifications or adaptations that will need to be made to sustain the intervention over time (e.g., lower cost, different staff, reduced intensity, different settings)?

...